The longest period in which conclusions on PDAC incidence after drug usage were made was seven years, which was a population-based cohort study 42
When comparing results between treatment groups, a one-way ANOVA with Tukeys multiple comparison test was used
Eur Rev Med Pharmacol Sci
According to Pande et al., dietary thyroxine could cause an increase in carnitine levels in the liver and serum, while carnitine levels in the heart, skeletal muscle, and the urinary excretion of carnitine remained unaffected in experimental rats [27]
It also enhances the expression of type IIa muscle fiberspecific genes, including MyHC I, Troponin I1 (TNNI1), and Troponin C1 (TNNC1), and inhibits the expression of type IIb muscle fiberspecific genes ( MyHC IIa , MyHC IIx , MyHC IIb ) by binding to various transcription factors such as NRF1 and MEF2 (117)